ATE447960T1 - Antivirale verwendung von borinsäurekomplexen - Google Patents

Antivirale verwendung von borinsäurekomplexen

Info

Publication number
ATE447960T1
ATE447960T1 AT05856817T AT05856817T ATE447960T1 AT E447960 T1 ATE447960 T1 AT E447960T1 AT 05856817 T AT05856817 T AT 05856817T AT 05856817 T AT05856817 T AT 05856817T AT E447960 T1 ATE447960 T1 AT E447960T1
Authority
AT
Austria
Prior art keywords
acid complexes
boric acid
antiviral use
antiviral
complexes
Prior art date
Application number
AT05856817T
Other languages
English (en)
Inventor
Carolyn Bellinger-Kawahara
Kirk R Maples
Jacob J Plattner
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE447960T1 publication Critical patent/ATE447960T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05856817T 2004-06-14 2005-06-14 Antivirale verwendung von borinsäurekomplexen ATE447960T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57941904P 2004-06-14 2004-06-14
PCT/US2005/020978 WO2006085932A2 (en) 2004-06-14 2005-06-14 Anti-viral uses of borinic acid complexes

Publications (1)

Publication Number Publication Date
ATE447960T1 true ATE447960T1 (de) 2009-11-15

Family

ID=36623539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05856817T ATE447960T1 (de) 2004-06-14 2005-06-14 Antivirale verwendung von borinsäurekomplexen

Country Status (12)

Country Link
US (1) US7393856B2 (de)
EP (1) EP1765360B1 (de)
JP (1) JP2008502694A (de)
AT (1) ATE447960T1 (de)
BR (1) BRPI0512049A (de)
CA (1) CA2570577A1 (de)
DE (1) DE602005017626D1 (de)
ES (1) ES2333244T3 (de)
MX (1) MXPA06014417A (de)
PT (1) PT1765360E (de)
TW (1) TW200612967A (de)
WO (1) WO2006085932A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1965647A2 (de) * 2005-12-28 2008-09-10 Anacor Pharmaceuticals, Inc. Verfahren zur herstellung von picolinat-borin-estern
HRP20150710T1 (hr) 2006-02-16 2015-08-14 Anacor Pharmaceuticals, Inc. Male molekule koje sadrže bor kao protu-upalni agensi
WO2010018837A2 (ja) * 2008-08-11 2010-02-18 独立行政法人科学技術振興機構 蛋白質架橋阻害剤
US8980544B2 (en) 2012-11-27 2015-03-17 The Penn State Research Foundation Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
KR101666331B1 (ko) 2013-01-30 2016-10-13 다우 아그로사이언시즈 엘엘씨 육류, 식물, 또는 식물 부분에 대한 휘발성 항미생물제로서의 벤족사보롤의 용도
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (de) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. Neuartige oxaborolanaloga und verwendungen davon
TWI794742B (zh) * 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
US20230340530A1 (en) 2020-08-31 2023-10-26 Pfizer Inc. Methods of Protecting RNA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5788800A (en) 1999-07-07 2001-01-22 Du Pont Pharmaceuticals Company Peptide boronic acid inhibitors of hepatitis c virus protease
MXPA05006685A (es) 2002-12-18 2005-12-14 Anacor Pharmaceuticals Inc Antibioticos que contienen complejos de acido borinico y metodos de uso.

Also Published As

Publication number Publication date
BRPI0512049A (pt) 2008-02-06
TW200612967A (en) 2006-05-01
US7393856B2 (en) 2008-07-01
EP1765360B1 (de) 2009-11-11
JP2008502694A (ja) 2008-01-31
CA2570577A1 (en) 2006-08-17
EP1765360A2 (de) 2007-03-28
MXPA06014417A (es) 2007-03-08
WO2006085932A2 (en) 2006-08-17
DE602005017626D1 (de) 2009-12-24
PT1765360E (pt) 2009-12-24
WO2006085932A3 (en) 2006-10-05
HK1102702A1 (en) 2007-11-30
ES2333244T3 (es) 2010-02-18
US20060019927A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
ATE447960T1 (de) Antivirale verwendung von borinsäurekomplexen
DK1558616T4 (da) Meso-substituerede porphyriner
EA200802213A1 (ru) Способы лечения заболеваний крови
NO20060664L (no) N-substituerte benzimidazolyl C-kit inhibitorer
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
CY1110084T1 (el) Χρηση συμπυκνωμενων ετεροκυκλικων ενωσεων ως αναστολεις scce για την θεραπευτικη αγωγη δερματικων ασθενειων
EA200701114A1 (ru) Азоловые производные с антимускариновой активностью
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
ATE408601T1 (de) Fredericamycin-derivate
ATE368034T1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
EA200600689A1 (ru) Замещённые бензазолы и их применение в качестве ингибиторов raf киназы
TW200509892A (en) Novel aminobenzophenone compounds
NO20060670L (no) N3-substituerte imidazopyridin C-kit inhibitorer
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
TW200612966A (en) Boron-containing compounds and methods of use
MA35895B1 (fr) Inhibiteurs d'iap
BR0310055A (pt) Derivados de piridinacarboxamida pesticidas
WO2007048002A3 (en) Camptothecin derivatives as chemoradiosensitizing agents
DE60328603D1 (de) Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
DE502006005100D1 (de) Verwendung von eisen(iii)-komplexverbindungen
TW200610530A (en) Anti-parasitic uses of borinic acid complexes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties